Discordant results from "real-world" patient samples assayed for digoxin

Annals of Pharmacotherapy

Volumn 42, Issue 12, 2008, Pages 1797-1803

  Jones, Terry E ^a   Morris, Raymond G ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Digoxin; Immunoassays; Therapeutic drug monitoring

Indexed keywords

DIGOXIN;

ADULT; AGED; ARTICLE; CALCULATION; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CROSS REACTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; FEMALE; HEART ATRIUM FIBRILLATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; IMMUNOREACTIVITY; KIDNEY DYSFUNCTION; LABORATORY DIAGNOSIS; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; SAMPLING; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; CARDENOLIDES; CARDIOTONIC AGENTS; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FEMALE; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SAPONINS;

EID: 57449115755     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1L225     Document Type: Article

References (20)

1. Therapeutic non-equivalence. Br Med J 1972;5827:599-600.
2. Danon A, Horowitz J, Ben-Zvi B, Kaplanski J, Glick S. An outbreak of digoxin intoxication. Clin Pharmacol Ther 1977;21:643-6.
3. Koch-Weser J. Therapeutic importance of bioavailability factors. N Engl J Med 1974;291:503-6.
4. Gruber KA, Whitaker JM, Buckalew VM. Endogenous digitalis-like substance in plasma of volume-expanded dogs. Nature 1980;287:743-5.
5. Morris RG, Frewin DB, Taylor WB, Glistak ML, Lehmann DR. The effect of renal and hepatic impairment and of spironolactone on digoxin assays. Eur J Clin Pharmacol 1988;34:233-40.
6. Dasgupta A, Saffer H, Wells A, Datta P. Bidirectional (positive/negative) interference of spironolactone, canrenone and potassium canrenoate on serum digoxin measurement: elimination of interference by measuring free digoxin or using a chemiluminescent assay for digoxin. J Clin Lab Anal 2002;16:172-7.
7. Datta P, Hinz V, Klee G. Comparison of four digoxin immunoassays with respect to interference from digoxin-like immunoreactive factors. Clin Biochem 1996;29:541-7.
8. Dasgupta A, Kang E, Olsen M, Actor JK, Datta P. New enzyme-linked chemiluminescent immunosorbent digoxin assay is free from interference of Chinese medicine DanShen. Ther Drug Monit 2006;28:775-8.
9. Dasgupta A, Wu S, Olsen M, Wells A, Datta P. Effect of Asian and Siberian ginseng on serum digoxin measurement by five immunoassays: significant variation in digoxin-like immunoreactivity among commercial ginsengs. Am J Clin Pathol 2003;119:298-303.
10. Morris RG, Frewin DB, Saccoia NC, McPhee AJ, Goldsworthy WL. Digoxin-like immunoreactive substance levels in cord blood obtained from twins. Eur J Clin Pharmacol 1991;40:199-200.
11. Liendo C, Ghali K, Graves SW. A new interference in some digoxin assays: anti-murine heterophilic antibodies. Clin Pharmacol Ther 1996;60:593-8.
12. Morris RG. Immunosuppressant drug monitoring. Is the laboratory meeting clinical expectations? Ann Pharmacother 2005;39:119-27. Epub 8 Dec 2004. DOI 10.1345/aph.1E287
13. Tzou MC, Sams RS, Reuning RH. Specific and sensitive determination of digoxin and metabolites in human serum by high performance liquid chromatography with cyclodextrin solid-phase extraction and precolumn fluorescence derivatization. J Pharm Biomed Anal 1995;13:1531-40.
14. Mitamura K, Horikawa A, Yamane Y, Ikeda Y, Fujii Y, Shimada K. Determination of digoxin in human serum using stable isotope dilution liquid chromatography/electrospray ionization-tandem mass spectrometry. Biol Pharm Bull 2007;30:1653-6.
15. Konishi H, Shimizu S, Chiba M, Minouchi T, Koida M, Yamaji A. Predictive performance of serum digoxin concentration in patients with congestive heart failure by a hyperbolic model based upon creatinine clearance. J Clin Pharm Ther 2002;27:257-65.
16. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8.
17. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-10.
19. Morris RG, Jones TE, Goldsworthy SJ, Wagner TJ, Ho H, Horowitz JD. Suspected DLIS interference in the Dimension DGNA digoxin assay method and the clinical application of the revised digoxin target range. Ther Drug Monit 2006;28:454-7.
20. Dasgupta A, Scott J. Unexpected suppression of total digoxin concentrations by cross-reactants in the microparticular enzyme immunoassay: elimination of interference by monitoring free digoxin concentration. Am J Clin Pathol 1998;110:78-82.